1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing prevalence of chronic and infectious diseases.
4.1.2 Initiatives implemented by government and not-for-profit associations for rising health awareness.
4.1.3 Technological advancements and adoption of a home-based point of care devices and new product launches.
4.1.4 Increase in worldwide expenditures on healthcare.
4.1.5 Increase in usage of home-based POC devices due to the shortage of skilled laboratory technicians.
4.2 Restraints
4.2.1 Lack of coordination among organisations (healthcare).
4.2.2 High procedure costs.
4.2.3 Inadequate reimbursement policies for point of care diagnostics devices.
4.2.4 Product prices and hampering profits.
4.2.5 Time-consuming policies, therefore, increasing gestation period for product launches.
4.3 Opportunities
4.3.1 Miniaturization of testing devices.
4.3.2 Developing economies after lucrative growth opportunities and increasing number of conferences and events.
4.4 Challenges
4.4.1 Irresponsible towards the change of treatment practices.
4.4.2 Lack of professionals and lack of knowledge on POC devices.
5. Point of Care Diagnostics Market - By Product
5.1 Introduction
5.2 Infectious diseases
5.3 Cardio metabolic kits
5.4 Glucose monitoring kits
5.5 Oncology markers
5.6 Coagulation
5.7 Urinalysis
5.8 OTC diagnostics test
5.9 Drugs of abuse
5.10 Blood gas testing
5.11 Fertility testing
5.12 Others
6. Point of Care Diagnostics Market - By mode of delivery
6.1 Introduction
6.2 OTC testing
6.3 Prescription
7. Point of Care Diagnostics Market - By End-user
7.1 Introduction
7.2 Hospitals
7.3 Research laboratories
7.4 Home healthcare
7.5 Others
8. Point of Care Diagnostics Market - By Geography
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.1.5 Others
8.2 Europe
8.2.1 Introduction
8.2.2 France
8.2.3 Germany
8.2.4 Italy
8.2.5 United Kingdom
8.2.6 Spain
8.2.7 Russia
8.2.8 Others
8.3 Asia-pacific
8.3.1 Introduction
8.3.2 China
8.3.3 Japan
8.3.4 India
8.3.5 Australia & New Zealand
8.3.6 Others
8.4 South America
8.4.1 Introduction
8.4.2 Brazil
8.4.3 Argentina
8.4.4 Others
8.5 the Middle East and Africa
8.5.1 Introduction
8.5.2 Middle East
8.5.3 Africa
9 Point of Care Diagnostics - Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted by Top Companies
10. Point of Care Diagnostics - Company Profiles
10.1 Roche diagnostics
10.2 Abbott Laboratories
10.3 Siemens AG
10.4 Johnson & Johnson
10.5 Alere Inc.
10.6 Nova biomedical
10.7 Instrumentation laboratory
10.8 PTs diagnostics
10.9 Beckman Coulter, Inc.
10.10 Becton, Dikinson & Company
10.11 Agendia
10.12 Hologic
10.13 Cephied
10.14 Illumina
10.15 Bayer AG
10.16 Danaher Corporation
10.17 Genomic health
11. Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
12 Appendix
12.1 List of Tables
12.2 List of Figures
